Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Apr 19.
Published in final edited form as: Sex Transm Infect. 2017 Mar;93(2):144. doi: 10.1136/sextrans-2016-052980

Group sex event participation: a link to STI risk among African-American heterosexual men incarcerated in North Carolina

Joy D Scheidell 1, Samuel R Friedman 2, Carol Golin 3, David A Wohl 4, Maria R Khan 1
PMCID: PMC5906732  NIHMSID: NIHMS958477  PMID: 28213578

Group sex events (GSEs) among heterosexuals and other groups may facilitate STI transmission by contributing to rapid partner exchange and links to high-risk partners.1,2 Using baseline (in-prison) data from DISRUPT (Disruption of Intimate Stable Relationships Unique to the Prison Term) (n=142), a cohort study conducted among African-American men incarcerated in North Carolina, USA, who were in committed heterosexual relationships at prison entry, we measured preincarceration GSE participation and other sexual risk behaviours. We tested urine samples for STI (chlamydia, gonorrhoea and trichomoniasis) using nucleic acid amplification tests. Approximately 16% reported GSE participation. GSE was strongly associated with STI (adjusted OR=6.59, 95% CI 1.78 to 24.42) but not with sexual risk behaviours (table 1). Since GSE participation was not associated with sexual risk behaviours, the association of GSE participation with infection suggests that GSEs may facilitate STI transmission through sex with infected partners. Programmes might intervene at GSE venues or through off-site approaches to GSE attendees. Preliminary results from this analysis were presented at the 2014 STD Prevention Conference.

Table 1.

Associations between group sex event (GSE) participation and sexual risk behaviours and STI in the 6 months before incarceration among 142 African-American men incarcerated in North Carolina

Outcome* % with outcome OR (95% CI) Adjusted OR (95% CI)
Biologically confirmed current (prevalent) STI
 Participated in GSE 26.1 6.53 (1.89 to 22.59) 6.59 (1.78 to 24.42)
 Did not participate in GSE 5.1 Referent Referent
Self-reported past STI
 Participated in GSE 54.6 2.56 (1.02 to 6.44) 2.02 (0.77 to 5.33)
 Did not participate in GSE 31.9 Referent Referent
Inconsistent condom use with new/casual partners
 Participated in GSE 52.1 0.99 (0.41 to 2.45) 0.99 (0.37 to 2.66)
 Did not participate in GSE 52.2 Referent Referent
Multiple (≥2)/concurrent partnerships
 Participated in GSE 56.5 1.39 (0.57 to 3.43) 1.37 (0.52 to 3.57)
 Did not participate in GSE 48.3 Referent Referent
Sex while drunk
 Participated in GSE 87.0 3.29 (0.92 to 11.75) 2.67 (0.73 to 9.79)
 Did not participate in GSE 67.0 Referent Referent
Sex while high
 Participated in GSE 73.9 1.36 (0.50 to 3.73) 1.05 (0.36 to 3.09)
 Did not participate in GSE 67.5 Referent Referent
Sex with partners who ever sold sex
 Participated in GSE 13.0 2.75 (0.64 to 11.91) 1.56 (0.30 to 8.25)
 Did not participate in GSE 5.2 Referent Referent
Sex with partners who are non-monogamous
 Participated in GSE 26.1 1.16 (0.42 to 3.24) 0.81 (0.28 to 2.34)
 Did not participate in GSE 23.3 Referent Referent
Sex with partners who ever had an STI
 Participated in GSE 17.4 1.33 (0.40 to 4.41) 1.43 (0.41 to 5.00)
 Did not participate in GSE 13.7 Referent Referent
Sex with partners who ever used crack
 Participated in GSE 13.6 2.13 (0.52 to 8.76) 1.91 (0.37 to 9.86)
 Did not participate in GSE 6.9 Referent Referent
*

Prevalence of outcomes in total sample (n=142): multiple (≥2)/concurrent partnerships=49.3%; sex while drunk=70.1%; sex while high=68.1%; sex with partners who ever sold sex=6.3%; sex with partners who are non-monogamous=28.5%; sex with partners who ever had an STI=6.9%; sex with partners who ever used crack=7.6%; inconsistent condom use with new/casual partners=50.0%; self-reported previous STI=34.7%; biologically confirmed prevalent STI=8.3%.

Adjusted for age and antisocial personality disorder.

Acknowledgments

Funding National Institute on Drug Abuse (R01DA028766).

Footnotes

Contributors JDS conducted the analyses, wrote the first draft of the letter and revised subsequent drafts; SF created the indicators of GSEs in the baseline survey and guided the analyses and interpretation of results; CG is a coinvestigator on project DISRUPT, advised in the conceptualisation of all aspects of the parent study and contributed to the current letter by assisting in interpreting results and writing the letter; DAW is the site principal investigator on Project DISRUPT, oversaw day-to-day operations of the study and contributed to the letter by assisting in interpreting the findings; MRK is the principal investigator of Project DISRUPT, conceptualised and conducted the parent study and guided the current letter analyses. All authors reviewed and revised the original draft of the letter and have approved this version.

Competing interests None declared.

Ethics approval New York University School of Medicine Institutional Review Board (i14-01540).

Provenance and peer review Not commissioned; internally peer reviewed.

References

  • 1.Friedman SR, Bolyard M, Khan M, et al. Group sex events and HIV/STI risk in an urban network. J Acquir Immune Defic Syndr. 2008;49:440–6. doi: 10.1097/qai.0b013e3181893f31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Friedman SR, Mateu-Gelabert P, Sandoval M. Group sex events amongst non-gay drug users: an understudied risk environment. Int J Drug Policy. 2011;22:1–8. doi: 10.1016/j.drugpo.2010.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES